A New Approach to Enhancing Immune Response in Pancreatic Cancer Treatment
Editor: Tiffany Researchers have developed a novel hydrogel microsphere vaccine that significantly boosts immune responses against pancreatic cancer following ablation therapy, potentially improving patient survival rates. Key Highlights Pancreatic Cancer…
Personalized mRNA Vaccine May Delay Pancreatic Cancer Recurrence
According to a phase I clinical trial published in Nature, a novel personalized RNA neoantigen vaccine combined with immunotherapy and chemotherapy has demonstrated significant potential to delay pancreatic cancer. Background…